Innate Pharma Stock (IPHA)
Track Innate Pharma stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
IPHA
Innate Pharma
healthcare
$1.77
▼ -0.41 (-18.98%) past year
Market Cap
$169.01M
P/E Ratio
—
1Y Return
-18.98%
EPS (TTM)
-$0.61
Read the latest TheStreet Pro articles mentioning Innate Pharma, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning IPHA yet.
Daily Diary Mentions
0 mentionsNo diary mentions for IPHA yet.